The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|1|16-25

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-01, pp. : 16-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

Potential and Current Use of N -Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging

By Le D.A.  

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 522-537

Bentham Science Publishers

Access to resources Recommend Favorite

N-methyl-D-aspartate antagonists for stroke and head trauma

By Wood P.L.   Hawkinson J.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 389-397

Informa Healthcare

Access to resources Recommend Favorite

Colonic mucosal N‐methyl‐D‐aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome

By  

Journal of Digestive Diseases, Vol. 17, Iss. 7, 2016-07 ,pp. : 448-457

John Wiley & Sons Inc

Access to resources Recommend Favorite